(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 21.89% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.79%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.95%.
Evolent Health's revenue in 2026 is $1,888,826,000.On average, 17 Wall Street analysts forecast EVH's revenue for 2026 to be $284,239,656,309, with the lowest EVH revenue forecast at $268,154,863,728, and the highest EVH revenue forecast at $308,423,085,714. On average, 17 Wall Street analysts forecast EVH's revenue for 2027 to be $335,643,503,928, with the lowest EVH revenue forecast at $294,587,914,473, and the highest EVH revenue forecast at $373,212,180,306.
In 2028, EVH is forecast to generate $383,672,919,537 in revenue, with the lowest revenue forecast at $322,145,775,888 and the highest revenue forecast at $436,201,577,826.